Global Radioligand Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Radioligand Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Radioligand Therapy industry chain, the market status of Neuroendocrine Neoplasms (Actinium 225 (Ac-225), Lutetium 177 (Lu-177)), Prostate Cancer (Actinium 225 (Ac-225), Lutetium 177 (Lu-177)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioligand Therapy.

Regionally, the report analyzes the Radioligand Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioligand Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Radioligand Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioligand Therapy industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Actinium 225 (Ac-225), Lutetium 177 (Lu-177)).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioligand Therapy market.

Regional Analysis: The report involves examining the Radioligand Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioligand Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Radioligand Therapy:
Company Analysis: Report covers individual Radioligand Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioligand Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Neuroendocrine Neoplasms, Prostate Cancer).

Technology Analysis: Report covers specific technologies relevant to Radioligand Therapy. It assesses the current state, advancements, and potential future developments in Radioligand Therapy areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioligand Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Radioligand Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Actinium 225 (Ac-225)
    Lutetium 177 (Lu-177)
    Gallium 68 (Ga-68)
    Fluorine 18 (F-18)
    Other Radionuclides

Market segment by Application
    Neuroendocrine Neoplasms
    Prostate Cancer

Market segment by players, this report covers
    Novartis
    Advanced Accelerator Applications
    Mercy Radiology
    POINT Biopharma Global Inc
    Fusion Pharma
    Telix Pharmaceuticals Ltd
    Lantheus Holdings, Inc
    Bayer AG
    Curium Pharma
    Precirix

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radioligand Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioligand Therapy, with revenue, gross margin and global market share of Radioligand Therapy from 2019 to 2024.
Chapter 3, the Radioligand Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Radioligand Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioligand Therapy.
Chapter 13, to describe Radioligand Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Radioligand Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Radioligand Therapy by Type
        1.3.1 Overview: Global Radioligand Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Radioligand Therapy Consumption Value Market Share by Type in 2023
        1.3.3 Actinium 225 (Ac-225)
        1.3.4 Lutetium 177 (Lu-177)
        1.3.5 Gallium 68 (Ga-68)
        1.3.6 Fluorine 18 (F-18)
        1.3.7 Other Radionuclides
    1.4 Global Radioligand Therapy Market by Application
        1.4.1 Overview: Global Radioligand Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Neuroendocrine Neoplasms
        1.4.3 Prostate Cancer
    1.5 Global Radioligand Therapy Market Size & Forecast
    1.6 Global Radioligand Therapy Market Size and Forecast by Region
        1.6.1 Global Radioligand Therapy Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Radioligand Therapy Market Size by Region, (2019-2030)
        1.6.3 North America Radioligand Therapy Market Size and Prospect (2019-2030)
        1.6.4 Europe Radioligand Therapy Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Radioligand Therapy Market Size and Prospect (2019-2030)
        1.6.6 South America Radioligand Therapy Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Radioligand Therapy Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Radioligand Therapy Product and Solutions
        2.1.4 Novartis Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Advanced Accelerator Applications
        2.2.1 Advanced Accelerator Applications Details
        2.2.2 Advanced Accelerator Applications Major Business
        2.2.3 Advanced Accelerator Applications Radioligand Therapy Product and Solutions
        2.2.4 Advanced Accelerator Applications Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Advanced Accelerator Applications Recent Developments and Future Plans
    2.3 Mercy Radiology
        2.3.1 Mercy Radiology Details
        2.3.2 Mercy Radiology Major Business
        2.3.3 Mercy Radiology Radioligand Therapy Product and Solutions
        2.3.4 Mercy Radiology Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Mercy Radiology Recent Developments and Future Plans
    2.4 POINT Biopharma Global Inc
        2.4.1 POINT Biopharma Global Inc Details
        2.4.2 POINT Biopharma Global Inc Major Business
        2.4.3 POINT Biopharma Global Inc Radioligand Therapy Product and Solutions
        2.4.4 POINT Biopharma Global Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 POINT Biopharma Global Inc Recent Developments and Future Plans
    2.5 Fusion Pharma
        2.5.1 Fusion Pharma Details
        2.5.2 Fusion Pharma Major Business
        2.5.3 Fusion Pharma Radioligand Therapy Product and Solutions
        2.5.4 Fusion Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Fusion Pharma Recent Developments and Future Plans
    2.6 Telix Pharmaceuticals Ltd
        2.6.1 Telix Pharmaceuticals Ltd Details
        2.6.2 Telix Pharmaceuticals Ltd Major Business
        2.6.3 Telix Pharmaceuticals Ltd Radioligand Therapy Product and Solutions
        2.6.4 Telix Pharmaceuticals Ltd Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Telix Pharmaceuticals Ltd Recent Developments and Future Plans
    2.7 Lantheus Holdings, Inc
        2.7.1 Lantheus Holdings, Inc Details
        2.7.2 Lantheus Holdings, Inc Major Business
        2.7.3 Lantheus Holdings, Inc Radioligand Therapy Product and Solutions
        2.7.4 Lantheus Holdings, Inc Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Lantheus Holdings, Inc Recent Developments and Future Plans
    2.8 Bayer AG
        2.8.1 Bayer AG Details
        2.8.2 Bayer AG Major Business
        2.8.3 Bayer AG Radioligand Therapy Product and Solutions
        2.8.4 Bayer AG Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Bayer AG Recent Developments and Future Plans
    2.9 Curium Pharma
        2.9.1 Curium Pharma Details
        2.9.2 Curium Pharma Major Business
        2.9.3 Curium Pharma Radioligand Therapy Product and Solutions
        2.9.4 Curium Pharma Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Curium Pharma Recent Developments and Future Plans
    2.10 Precirix
        2.10.1 Precirix Details
        2.10.2 Precirix Major Business
        2.10.3 Precirix Radioligand Therapy Product and Solutions
        2.10.4 Precirix Radioligand Therapy Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Precirix Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Radioligand Therapy Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Radioligand Therapy by Company Revenue
        3.2.2 Top 3 Radioligand Therapy Players Market Share in 2023
        3.2.3 Top 6 Radioligand Therapy Players Market Share in 2023
    3.3 Radioligand Therapy Market: Overall Company Footprint Analysis
        3.3.1 Radioligand Therapy Market: Region Footprint
        3.3.2 Radioligand Therapy Market: Company Product Type Footprint
        3.3.3 Radioligand Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Radioligand Therapy Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Radioligand Therapy Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Radioligand Therapy Consumption Value Market Share by Application (2019-2024)
    5.2 Global Radioligand Therapy Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Radioligand Therapy Consumption Value by Type (2019-2030)
    6.2 North America Radioligand Therapy Consumption Value by Application (2019-2030)
    6.3 North America Radioligand Therapy Market Size by Country
        6.3.1 North America Radioligand Therapy Consumption Value by Country (2019-2030)
        6.3.2 United States Radioligand Therapy Market Size and Forecast (2019-2030)
        6.3.3 Canada Radioligand Therapy Market Size and Forecast (2019-2030)
        6.3.4 Mexico Radioligand Therapy Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Radioligand Therapy Consumption Value by Type (2019-2030)
    7.2 Europe Radioligand Therapy Consumption Value by Application (2019-2030)
    7.3 Europe Radioligand Therapy Market Size by Country
        7.3.1 Europe Radioligand Therapy Consumption Value by Country (2019-2030)
        7.3.2 Germany Radioligand Therapy Market Size and Forecast (2019-2030)
        7.3.3 France Radioligand Therapy Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Radioligand Therapy Market Size and Forecast (2019-2030)
        7.3.5 Russia Radioligand Therapy Market Size and Forecast (2019-2030)
        7.3.6 Italy Radioligand Therapy Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Radioligand Therapy Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Radioligand Therapy Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Radioligand Therapy Market Size by Region
        8.3.1 Asia-Pacific Radioligand Therapy Consumption Value by Region (2019-2030)
        8.3.2 China Radioligand Therapy Market Size and Forecast (2019-2030)
        8.3.3 Japan Radioligand Therapy Market Size and Forecast (2019-2030)
        8.3.4 South Korea Radioligand Therapy Market Size and Forecast (2019-2030)
        8.3.5 India Radioligand Therapy Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Radioligand Therapy Market Size and Forecast (2019-2030)
        8.3.7 Australia Radioligand Therapy Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Radioligand Therapy Consumption Value by Type (2019-2030)
    9.2 South America Radioligand Therapy Consumption Value by Application (2019-2030)
    9.3 South America Radioligand Therapy Market Size by Country
        9.3.1 South America Radioligand Therapy Consumption Value by Country (2019-2030)
        9.3.2 Brazil Radioligand Therapy Market Size and Forecast (2019-2030)
        9.3.3 Argentina Radioligand Therapy Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Radioligand Therapy Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Radioligand Therapy Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Radioligand Therapy Market Size by Country
        10.3.1 Middle East & Africa Radioligand Therapy Consumption Value by Country (2019-2030)
        10.3.2 Turkey Radioligand Therapy Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Radioligand Therapy Market Size and Forecast (2019-2030)
        10.3.4 UAE Radioligand Therapy Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Radioligand Therapy Market Drivers
    11.2 Radioligand Therapy Market Restraints
    11.3 Radioligand Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Radioligand Therapy Industry Chain
    12.2 Radioligand Therapy Upstream Analysis
    12.3 Radioligand Therapy Midstream Analysis
    12.4 Radioligand Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Radioligand Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Radioligand Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Radioligand Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Radioligand Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Novartis Company Information, Head Office, and Major Competitors
    Table 6. Novartis Major Business
    Table 7. Novartis Radioligand Therapy Product and Solutions
    Table 8. Novartis Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Novartis Recent Developments and Future Plans
    Table 10. Advanced Accelerator Applications Company Information, Head Office, and Major Competitors
    Table 11. Advanced Accelerator Applications Major Business
    Table 12. Advanced Accelerator Applications Radioligand Therapy Product and Solutions
    Table 13. Advanced Accelerator Applications Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Advanced Accelerator Applications Recent Developments and Future Plans
    Table 15. Mercy Radiology Company Information, Head Office, and Major Competitors
    Table 16. Mercy Radiology Major Business
    Table 17. Mercy Radiology Radioligand Therapy Product and Solutions
    Table 18. Mercy Radiology Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Mercy Radiology Recent Developments and Future Plans
    Table 20. POINT Biopharma Global Inc Company Information, Head Office, and Major Competitors
    Table 21. POINT Biopharma Global Inc Major Business
    Table 22. POINT Biopharma Global Inc Radioligand Therapy Product and Solutions
    Table 23. POINT Biopharma Global Inc Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. POINT Biopharma Global Inc Recent Developments and Future Plans
    Table 25. Fusion Pharma Company Information, Head Office, and Major Competitors
    Table 26. Fusion Pharma Major Business
    Table 27. Fusion Pharma Radioligand Therapy Product and Solutions
    Table 28. Fusion Pharma Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Fusion Pharma Recent Developments and Future Plans
    Table 30. Telix Pharmaceuticals Ltd Company Information, Head Office, and Major Competitors
    Table 31. Telix Pharmaceuticals Ltd Major Business
    Table 32. Telix Pharmaceuticals Ltd Radioligand Therapy Product and Solutions
    Table 33. Telix Pharmaceuticals Ltd Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Telix Pharmaceuticals Ltd Recent Developments and Future Plans
    Table 35. Lantheus Holdings, Inc Company Information, Head Office, and Major Competitors
    Table 36. Lantheus Holdings, Inc Major Business
    Table 37. Lantheus Holdings, Inc Radioligand Therapy Product and Solutions
    Table 38. Lantheus Holdings, Inc Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Lantheus Holdings, Inc Recent Developments and Future Plans
    Table 40. Bayer AG Company Information, Head Office, and Major Competitors
    Table 41. Bayer AG Major Business
    Table 42. Bayer AG Radioligand Therapy Product and Solutions
    Table 43. Bayer AG Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Bayer AG Recent Developments and Future Plans
    Table 45. Curium Pharma Company Information, Head Office, and Major Competitors
    Table 46. Curium Pharma Major Business
    Table 47. Curium Pharma Radioligand Therapy Product and Solutions
    Table 48. Curium Pharma Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Curium Pharma Recent Developments and Future Plans
    Table 50. Precirix Company Information, Head Office, and Major Competitors
    Table 51. Precirix Major Business
    Table 52. Precirix Radioligand Therapy Product and Solutions
    Table 53. Precirix Radioligand Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Precirix Recent Developments and Future Plans
    Table 55. Global Radioligand Therapy Revenue (USD Million) by Players (2019-2024)
    Table 56. Global Radioligand Therapy Revenue Share by Players (2019-2024)
    Table 57. Breakdown of Radioligand Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in Radioligand Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 59. Head Office of Key Radioligand Therapy Players
    Table 60. Radioligand Therapy Market: Company Product Type Footprint
    Table 61. Radioligand Therapy Market: Company Product Application Footprint
    Table 62. Radioligand Therapy New Market Entrants and Barriers to Market Entry
    Table 63. Radioligand Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global Radioligand Therapy Consumption Value (USD Million) by Type (2019-2024)
    Table 65. Global Radioligand Therapy Consumption Value Share by Type (2019-2024)
    Table 66. Global Radioligand Therapy Consumption Value Forecast by Type (2025-2030)
    Table 67. Global Radioligand Therapy Consumption Value by Application (2019-2024)
    Table 68. Global Radioligand Therapy Consumption Value Forecast by Application (2025-2030)
    Table 69. North America Radioligand Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 70. North America Radioligand Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 71. North America Radioligand Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. North America Radioligand Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. North America Radioligand Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 74. North America Radioligand Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 75. Europe Radioligand Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 76. Europe Radioligand Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 77. Europe Radioligand Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 78. Europe Radioligand Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 79. Europe Radioligand Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 80. Europe Radioligand Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 81. Asia-Pacific Radioligand Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 82. Asia-Pacific Radioligand Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 83. Asia-Pacific Radioligand Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 84. Asia-Pacific Radioligand Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 85. Asia-Pacific Radioligand Therapy Consumption Value by Region (2019-2024) & (USD Million)
    Table 86. Asia-Pacific Radioligand Therapy Consumption Value by Region (2025-2030) & (USD Million)
    Table 87. South America Radioligand Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 88. South America Radioligand Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 89. South America Radioligand Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 90. South America Radioligand Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 91. South America Radioligand Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 92. South America Radioligand Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 93. Middle East & Africa Radioligand Therapy Consumption Value by Type (2019-2024) & (USD Million)
    Table 94. Middle East & Africa Radioligand Therapy Consumption Value by Type (2025-2030) & (USD Million)
    Table 95. Middle East & Africa Radioligand Therapy Consumption Value by Application (2019-2024) & (USD Million)
    Table 96. Middle East & Africa Radioligand Therapy Consumption Value by Application (2025-2030) & (USD Million)
    Table 97. Middle East & Africa Radioligand Therapy Consumption Value by Country (2019-2024) & (USD Million)
    Table 98. Middle East & Africa Radioligand Therapy Consumption Value by Country (2025-2030) & (USD Million)
    Table 99. Radioligand Therapy Raw Material
    Table 100. Key Suppliers of Radioligand Therapy Raw Materials
List of Figures
    Figure 1. Radioligand Therapy Picture
    Figure 2. Global Radioligand Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Radioligand Therapy Consumption Value Market Share by Type in 2023
    Figure 4. Actinium 225 (Ac-225)
    Figure 5. Lutetium 177 (Lu-177)
    Figure 6. Gallium 68 (Ga-68)
    Figure 7. Fluorine 18 (F-18)
    Figure 8. Other Radionuclides
    Figure 9. Global Radioligand Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Radioligand Therapy Consumption Value Market Share by Application in 2023
    Figure 11. Neuroendocrine Neoplasms Picture
    Figure 12. Prostate Cancer Picture
    Figure 13. Global Radioligand Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Radioligand Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Radioligand Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Radioligand Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Radioligand Therapy Consumption Value Market Share by Region in 2023
    Figure 18. North America Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Radioligand Therapy Revenue Share by Players in 2023
    Figure 24. Radioligand Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Radioligand Therapy Market Share in 2023
    Figure 26. Global Top 6 Players Radioligand Therapy Market Share in 2023
    Figure 27. Global Radioligand Therapy Consumption Value Share by Type (2019-2024)
    Figure 28. Global Radioligand Therapy Market Share Forecast by Type (2025-2030)
    Figure 29. Global Radioligand Therapy Consumption Value Share by Application (2019-2024)
    Figure 30. Global Radioligand Therapy Market Share Forecast by Application (2025-2030)
    Figure 31. North America Radioligand Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Radioligand Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Radioligand Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Radioligand Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Radioligand Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Radioligand Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Radioligand Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Radioligand Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Radioligand Therapy Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Radioligand Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Radioligand Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Radioligand Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Radioligand Therapy Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Radioligand Therapy Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Radioligand Therapy Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Radioligand Therapy Consumption Value (2019-2030) & (USD Million)
    Figure 65. Radioligand Therapy Market Drivers
    Figure 66. Radioligand Therapy Market Restraints
    Figure 67. Radioligand Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Radioligand Therapy in 2023
    Figure 70. Manufacturing Process Analysis of Radioligand Therapy
    Figure 71. Radioligand Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

Novartis
Advanced Accelerator Applications
Mercy Radiology
POINT Biopharma Global Inc
Fusion Pharma
Telix Pharmaceuticals Ltd
Lantheus Holdings, Inc
Bayer AG
Curium Pharma
Precirix